COPD
-
Formulary decision guideStalpex (salmeterol xinafoate/fluticasone propionate)
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Glenmark Pharmaceuticals Europe Ltd in a format developed by Guidelines in Practice . View prescribing information here Key points Stalpex is a branded generic inhaled ...
-
Formulary decision guide
Symbicort® (budesonide/formoterol) for COPD
Information intended for healthcare professionals only. This formulary decision guide was commissioned by AstraZeneca UK Ltd, who had full editorial control, and was produced in a format developed by Guidelines in Practice . Indications Symbicort pMDI 200 μg/6 μg per actuation, pressurised inhalation suspension, Symbicort ...
-
Digital edition
February 2019 issue
The digital edition of the February 2019 issue of Guidelines in Practice , featuring articles on: COPD, covert medication, type 2 diabetes, and talking about weight with patients.
-
Implementing guidelines
GOLD 2019 report: a step towards personalised medicine
Professor David Halpin provides an overview of new recommendations in the latest revision to the GOLD COPD strategy
-
Test and reflect
GOLD 2019 guideline on chronic obstructive pulmonary disease
This CPD activity consists of 4 multiple-choice questions (MCQs) designed to test your knowledge on the implementation of the 2019 GOLD strategy on chronic obstructive pulmonary disease (COPD)—you will then be prompted to reflect on your learning.
-
Supplement
A comparison of once-daily triple therapy with once-daily dual therapy in the treatment of symptomatic COPD—the IMPACT trial
This supplement has been developed in partnership with GlaxoSmithKline. GlaxoSmithKline suggested the topic, funded production of the supplement, and suggested the author(s); the content has also been checked for factual accuracy to ensure it is fair and balanced, and to ensure its compliance with appropriate regulation. The sponsorship ...
-
News
2019 GOLD COPD strategy published
The Global Initiative for Chronic Obstructive Lung Disease has published the 2019 edition of the Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease.
-
Test and reflect
Best practice in assessing asthma–COPD overlap syndrome
This CPD activity consists of 5 multiple-choice questions designed to test your knowledge on asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome—you will then be prompted to reflect on your learning.
-
News
2018 GOLD COPD report published
The Global Initiative for Chronic Obstructive Lung Disease has published the 2018 edition of the Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease.
-
Differential diagnoses
Breathlessness: what's the diagnosis?
Dr Chris Cooper reflects on a variety of possible causes of breathlessness: asthma, atrial fibrillation, COPD, or something else?
